These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36647694)

  • 1. The association between serum folate and ultrasound - defined hepatic steatosis.
    Chen X; Lu J; Xu Q; Chen B; Shen L
    Ann Med; 2023 Dec; 55(1):456-462. PubMed ID: 36647694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between SII and hepatic steatosis and liver fibrosis: A population-based study.
    Xie R; Xiao M; Li L; Ma N; Liu M; Huang X; Liu Q; Zhang Y
    Front Immunol; 2022; 13():925690. PubMed ID: 36189280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density.
    Xie R; Liu M
    Front Endocrinol (Lausanne); 2022; 13():857110. PubMed ID: 35360054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.
    Chon YE; Jung KS; Kim SU; Park JY; Park YN; Kim DY; Ahn SH; Chon CY; Lee HW; Park Y; Han KH
    Liver Int; 2014 Jan; 34(1):102-9. PubMed ID: 24028214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled attenuation parameter accurately detects liver steatosis in people with HIV.
    Duarte M; Tien P; Ma Y; Noworolski SM; Korn N; Price JC
    AIDS; 2022 Dec; 36(15):2147-2152. PubMed ID: 35950941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
    Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound and FibroScan
    Salmi A; di Filippo L; Ferrari C; Frara S; Giustina A
    Endocrine; 2022 Nov; 78(2):262-269. PubMed ID: 35980569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
    Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
    Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.
    Runge JH; van Giessen J; Draijer LG; Deurloo EE; Smets AMJB; Benninga MA; Koot BGP; Stoker J
    Eur Radiol; 2021 Mar; 31(3):1588-1596. PubMed ID: 32910234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.
    Shen F; Zheng RD; Mi YQ; Wang XY; Pan Q; Chen GY; Cao HX; Chen ML; Xu L; Chen JN; Cao Y; Zhang RN; Xu LM; Fan JG
    World J Gastroenterol; 2014 Apr; 20(16):4702-11. PubMed ID: 24782622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.
    Ferraioli G; Calcaterra V; Lissandrin R; Guazzotti M; Maiocchi L; Tinelli C; De Silvestri A; Regalbuto C; Pelizzo G; Larizza D; Filice C
    BMC Gastroenterol; 2017 May; 17(1):61. PubMed ID: 28472948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid to creatinine ratio is associated with higher prevalence of NAFLD detected by FibroScan in the United States.
    Wang R; Xue F; Wang L; Shi G; Qian G; Yang N; Chen X
    J Clin Lab Anal; 2022 Aug; 36(8):e24590. PubMed ID: 35808891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018.
    Bae JC; Beste LA; Utzschneider KM
    Endocrinol Metab (Seoul); 2022 Jun; 37(3):455-465. PubMed ID: 35726152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography.
    Yilmaz Y; Ergelen R; Akin H; Imeryuz N
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1330-4. PubMed ID: 23660937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study.
    Yoo JJ; Yoo YJ; Moon WR; Kim SU; Jeong SW; Park HN; Park MG; Jang JY; Park SY; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim SG; Kim YS; Kim JH; Yeon JE; Byun KS
    Korean J Intern Med; 2020 Nov; 35(6):1346-1353. PubMed ID: 31694366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between alcohol consumption and hepatic steatosis in the USA.
    Niezen S; Trivedi HD; Mukamal KJ; Jiang ZG
    Liver Int; 2021 Sep; 41(9):2020-2023. PubMed ID: 34297882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
    J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.